ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026
De Novo Design of Multivalent α/β-Peptides Mimicking Transcription Factors Targeting the CBP KIX Domain.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Protein-protein interactions that regulate gene expression in the nucleus are increasingly recognized as potential therapeutic targets but present unique challenges. Effective targeting requires molecules capable of interacting with large protein surfaces while remaining small enough to pass through the nuclear pore, for which peptidomimetics are promising candidates. De novo design strategies often focus on projecting hot-spot residues using well-defined, rigid scaffolds; however, other critical properties-such as solubility, charge, or local flexibility-are often overlooked. Our approach employs α/β-peptidomimetics to enable fine-tuning of these properties by generating manageable-sized soluble libraries. Using the KIX domain of the coactivator proteins p300/CBP as a model system, we demonstrate that our strategy allows modular optimization of hot-spot, solvent-exposed, and structure-inducing residues, thereby tuning affinity and binding-site selectivity. Coactivator proteins often use multivalency to enhance affinity and selectivity, which we exploit by creating dimers from our initial hits. We show that both static libraries and template-directed dynamic covalent chemistry facilitate the screening of multivalent ligands that closely mimic the native interaction partners. Our design strategy, built on α/β-peptide building blocks, represents a promising approach to develop de novo ligands against proteins characterized by high plasticity and multivalent interactions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.